 Michael Chen
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 18 | 2018 | 340 | 3.780 |
Why?
| | Thrombectomy | 7 | 2018 | 50 | 2.360 |
Why?
| | Intracranial Aneurysm | 5 | 2016 | 85 | 2.120 |
Why?
| | Endovascular Procedures | 10 | 2018 | 78 | 2.100 |
Why?
| | Cerebral Angiography | 5 | 2016 | 71 | 1.910 |
Why?
| | Brain Ischemia | 9 | 2018 | 114 | 1.860 |
Why?
| | Embolization, Therapeutic | 5 | 2014 | 80 | 1.630 |
Why?
| | Intracranial Hemorrhages | 4 | 2017 | 18 | 1.460 |
Why?
| | Arteriovenous Fistula | 3 | 2016 | 8 | 1.360 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2016 | 12 | 1.290 |
Why?
| | Thrombolytic Therapy | 6 | 2014 | 84 | 1.280 |
Why?
| | Aneurysm, Ruptured | 2 | 2016 | 27 | 1.240 |
Why?
| | Arterial Occlusive Diseases | 4 | 2017 | 21 | 1.040 |
Why?
| | Cerebrovascular Disorders | 3 | 2015 | 107 | 0.790 |
Why?
| | Humans | 45 | 2021 | 29841 | 0.750 |
Why?
| | Patient Transfer | 1 | 2017 | 24 | 0.710 |
Why?
| | Stents | 4 | 2018 | 157 | 0.690 |
Why?
| | Female | 28 | 2021 | 17657 | 0.650 |
Why?
| | Middle Aged | 22 | 2019 | 11053 | 0.640 |
Why?
| | Tomography, X-Ray Computed | 6 | 2021 | 869 | 0.640 |
Why?
| | Informed Consent | 1 | 2015 | 24 | 0.630 |
Why?
| | Periodicals as Topic | 2 | 2015 | 40 | 0.620 |
Why?
| | Neurosurgery | 2 | 2015 | 45 | 0.620 |
Why?
| | Mandible | 2 | 2018 | 14 | 0.610 |
Why?
| | Self-Help Groups | 1 | 2014 | 8 | 0.610 |
Why?
| | Retrospective Studies | 15 | 2019 | 3303 | 0.600 |
Why?
| | Social Media | 1 | 2014 | 31 | 0.580 |
Why?
| | Aged | 20 | 2019 | 9833 | 0.570 |
Why?
| | Vascular Access Devices | 1 | 2013 | 9 | 0.570 |
Why?
| | Maxilla | 1 | 2013 | 2 | 0.570 |
Why?
| | Cerebral Arteries | 1 | 2013 | 37 | 0.550 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2014 | 91 | 0.550 |
Why?
| | Adult | 16 | 2021 | 9591 | 0.540 |
Why?
| | Neuralgia | 1 | 2012 | 15 | 0.520 |
Why?
| | Male | 26 | 2019 | 17153 | 0.510 |
Why?
| | Connexin 43 | 1 | 2012 | 19 | 0.510 |
Why?
| | Gap Junctions | 1 | 2012 | 21 | 0.510 |
Why?
| | Spinal Cord Injuries | 1 | 2012 | 42 | 0.500 |
Why?
| | Spinal Cord | 1 | 2012 | 99 | 0.480 |
Why?
| | Checklist | 1 | 2011 | 39 | 0.480 |
Why?
| | Aged, 80 and over | 13 | 2018 | 5016 | 0.470 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2010 | 5 | 0.470 |
Why?
| | Intraoperative Complications | 1 | 2011 | 75 | 0.470 |
Why?
| | Estrogen Replacement Therapy | 1 | 2010 | 22 | 0.460 |
Why?
| | Tibia | 1 | 2013 | 259 | 0.460 |
Why?
| | Astrocytes | 1 | 2012 | 127 | 0.460 |
Why?
| | Bone Transplantation | 1 | 2013 | 229 | 0.460 |
Why?
| | Device Removal | 1 | 2010 | 97 | 0.430 |
Why?
| | Polycystic Kidney Diseases | 1 | 2009 | 4 | 0.420 |
Why?
| | Connective Tissue Diseases | 1 | 2009 | 10 | 0.410 |
Why?
| | Predictive Value of Tests | 3 | 2017 | 617 | 0.410 |
Why?
| | Communicable Diseases | 1 | 2009 | 15 | 0.410 |
Why?
| | Migraine Disorders | 1 | 2009 | 20 | 0.410 |
Why?
| | Adolescent | 7 | 2018 | 2591 | 0.390 |
Why?
| | Neuroradiography | 1 | 2008 | 3 | 0.380 |
Why?
| | Radiology, Interventional | 1 | 2008 | 8 | 0.380 |
Why?
| | Heart Defects, Congenital | 1 | 2009 | 64 | 0.370 |
Why?
| | Vascular Surgical Procedures | 1 | 2008 | 55 | 0.360 |
Why?
| | Follow-Up Studies | 7 | 2018 | 2017 | 0.360 |
Why?
| | Education, Medical, Graduate | 1 | 2008 | 82 | 0.350 |
Why?
| | Inflammation | 1 | 2009 | 338 | 0.340 |
Why?
| | Neurology | 1 | 2008 | 107 | 0.340 |
Why?
| | Nanostructures | 1 | 2005 | 13 | 0.320 |
Why?
| | Morbidity | 2 | 2016 | 71 | 0.320 |
Why?
| | False Positive Reactions | 2 | 2017 | 40 | 0.320 |
Why?
| | Tissue Plasminogen Activator | 4 | 2015 | 76 | 0.320 |
Why?
| | Adenoviridae | 1 | 2005 | 33 | 0.320 |
Why?
| | Genetic Vectors | 1 | 2005 | 68 | 0.310 |
Why?
| | Blood-Brain Barrier | 1 | 2005 | 44 | 0.310 |
Why?
| | Magnetic Resonance Angiography | 2 | 2016 | 51 | 0.300 |
Why?
| | Prognosis | 4 | 2018 | 1025 | 0.300 |
Why?
| | Genetic Therapy | 1 | 2005 | 91 | 0.300 |
Why?
| | Aorta, Thoracic | 1 | 2004 | 21 | 0.290 |
Why?
| | Treatment Outcome | 9 | 2018 | 3788 | 0.290 |
Why?
| | Wounds, Nonpenetrating | 1 | 2004 | 22 | 0.290 |
Why?
| | Young Adult | 6 | 2018 | 2198 | 0.280 |
Why?
| | Physical Exertion | 1 | 2002 | 11 | 0.270 |
Why?
| | Catheter Ablation | 2 | 2013 | 74 | 0.250 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 382 | 0.250 |
Why?
| | Kidney Neoplasms | 2 | 2013 | 109 | 0.250 |
Why?
| | Child | 4 | 2015 | 1505 | 0.230 |
Why?
| | Lung Diseases | 1 | 2021 | 55 | 0.220 |
Why?
| | Angiography, Digital Subtraction | 2 | 2016 | 12 | 0.210 |
Why?
| | Drug-Eluting Stents | 1 | 2019 | 16 | 0.200 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2019 | 24 | 0.200 |
Why?
| | Pelvic Neoplasms | 1 | 2018 | 6 | 0.200 |
Why?
| | Animals | 6 | 2014 | 5125 | 0.200 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2018 | 9 | 0.200 |
Why?
| | Embolectomy | 2 | 2015 | 6 | 0.200 |
Why?
| | Cheek | 1 | 2018 | 2 | 0.200 |
Why?
| | Clinical Trials as Topic | 3 | 2015 | 382 | 0.200 |
Why?
| | Prognathism | 1 | 2018 | 2 | 0.200 |
Why?
| | Intraoperative Care | 1 | 2018 | 58 | 0.190 |
Why?
| | Taiwan | 2 | 2019 | 8 | 0.190 |
Why?
| | Radiotherapy, Intensity-Modulated | 2 | 2018 | 40 | 0.190 |
Why?
| | Fibrinolytic Agents | 3 | 2017 | 92 | 0.190 |
Why?
| | Renal Dialysis | 1 | 2019 | 104 | 0.190 |
Why?
| | Myocardial Infarction | 1 | 2019 | 188 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2016 | 357 | 0.180 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 210 | 0.180 |
Why?
| | Societies, Medical | 2 | 2015 | 202 | 0.170 |
Why?
| | Evidence-Based Medicine | 2 | 2015 | 233 | 0.170 |
Why?
| | Rupture, Spontaneous | 1 | 2016 | 8 | 0.170 |
Why?
| | Subdural Effusion | 1 | 2015 | 7 | 0.160 |
Why?
| | Research Report | 1 | 2015 | 9 | 0.160 |
Why?
| | Hematoma, Subdural, Acute | 1 | 2015 | 12 | 0.160 |
Why?
| | Neurologic Examination | 1 | 2016 | 159 | 0.160 |
Why?
| | Extracellular Fluid | 1 | 2014 | 4 | 0.150 |
Why?
| | Writing | 1 | 2015 | 17 | 0.150 |
Why?
| | Research Personnel | 1 | 2015 | 21 | 0.150 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 23 | 0.150 |
Why?
| | Posterior Cerebral Artery | 1 | 2014 | 3 | 0.150 |
Why?
| | Mice, Knockout | 2 | 2014 | 376 | 0.150 |
Why?
| | Medulloblastoma | 1 | 2014 | 6 | 0.150 |
Why?
| | Cerebellar Neoplasms | 1 | 2014 | 7 | 0.150 |
Why?
| | Radiation Tolerance | 1 | 2014 | 8 | 0.150 |
Why?
| | Aneurysm | 1 | 2014 | 15 | 0.150 |
Why?
| | Hearing Loss | 1 | 2014 | 15 | 0.150 |
Why?
| | Hearing | 1 | 2014 | 17 | 0.150 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 48 | 0.150 |
Why?
| | Brain Injuries | 1 | 2014 | 58 | 0.140 |
Why?
| | False Negative Reactions | 1 | 2013 | 16 | 0.140 |
Why?
| | Databases, Factual | 1 | 2016 | 357 | 0.140 |
Why?
| | tau Proteins | 1 | 2014 | 160 | 0.140 |
Why?
| | Neurofibrillary Tangles | 1 | 2014 | 170 | 0.140 |
Why?
| | Biomedical Research | 1 | 2014 | 85 | 0.140 |
Why?
| | Tissue and Organ Harvesting | 1 | 2013 | 25 | 0.140 |
Why?
| | Magnetic Resonance Imaging, Interventional | 1 | 2013 | 9 | 0.140 |
Why?
| | Patient Selection | 2 | 2015 | 249 | 0.140 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 83 | 0.140 |
Why?
| | Psychometrics | 1 | 2014 | 284 | 0.130 |
Why?
| | Neurosurgical Procedures | 1 | 2015 | 160 | 0.130 |
Why?
| | Mice | 3 | 2014 | 1805 | 0.130 |
Why?
| | Pain Threshold | 1 | 2012 | 25 | 0.130 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2012 | 37 | 0.130 |
Why?
| | Hospitalization | 1 | 2015 | 330 | 0.130 |
Why?
| | Hyperalgesia | 1 | 2012 | 42 | 0.130 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 144 | 0.130 |
Why?
| | Pilot Projects | 1 | 2013 | 425 | 0.120 |
Why?
| | Angioplasty | 2 | 2010 | 16 | 0.120 |
Why?
| | Ductus Arteriosus | 1 | 2011 | 1 | 0.120 |
Why?
| | Fetal Diseases | 1 | 2011 | 10 | 0.120 |
Why?
| | Heart Aneurysm | 1 | 2011 | 11 | 0.120 |
Why?
| | Foramen Ovale, Patent | 1 | 2011 | 12 | 0.120 |
Why?
| | Injections, Intra-Arterial | 1 | 2011 | 15 | 0.120 |
Why?
| | Transportation of Patients | 1 | 2011 | 10 | 0.120 |
Why?
| | Thromboembolism | 1 | 2011 | 38 | 0.120 |
Why?
| | Kidney | 1 | 2013 | 205 | 0.120 |
Why?
| | Infarction, Middle Cerebral Artery | 1 | 2011 | 24 | 0.120 |
Why?
| | Suction | 1 | 2011 | 45 | 0.110 |
Why?
| | Antifibrinolytic Agents | 1 | 2011 | 21 | 0.110 |
Why?
| | Assisted Circulation | 1 | 2010 | 6 | 0.110 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 56 | 0.110 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 181 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2013 | 915 | 0.110 |
Why?
| | Chicago | 1 | 2013 | 916 | 0.110 |
Why?
| | Hypothermia, Induced | 1 | 2010 | 23 | 0.110 |
Why?
| | Angioplasty, Balloon | 1 | 2009 | 28 | 0.110 |
Why?
| | Pain Measurement | 1 | 2012 | 470 | 0.110 |
Why?
| | Vasoconstriction | 1 | 2009 | 24 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2021 | 741 | 0.100 |
Why?
| | Logistic Models | 1 | 2010 | 478 | 0.100 |
Why?
| | Radiography | 1 | 2011 | 714 | 0.100 |
Why?
| | Hepatocyte Nuclear Factor 6 | 1 | 2008 | 1 | 0.100 |
Why?
| | Cholestasis, Extrahepatic | 1 | 2008 | 3 | 0.100 |
Why?
| | Human Growth Hormone | 1 | 2008 | 5 | 0.100 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2008 | 7 | 0.100 |
Why?
| | Risk Factors | 1 | 2016 | 2549 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2010 | 684 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2012 | 813 | 0.100 |
Why?
| | Intracranial Thrombosis | 1 | 2008 | 10 | 0.100 |
Why?
| | Medicine | 1 | 2008 | 11 | 0.100 |
Why?
| | Prospective Studies | 1 | 2013 | 1809 | 0.100 |
Why?
| | Specialization | 1 | 2008 | 17 | 0.090 |
Why?
| | Infant | 2 | 2014 | 652 | 0.090 |
Why?
| | Education, Medical | 1 | 2008 | 42 | 0.090 |
Why?
| | Teaching | 1 | 2008 | 62 | 0.090 |
Why?
| | Age Factors | 1 | 2010 | 912 | 0.090 |
Why?
| | Child, Preschool | 2 | 2014 | 785 | 0.090 |
Why?
| | Radiotherapy Dosage | 2 | 2018 | 146 | 0.090 |
Why?
| | Recovery of Function | 1 | 2008 | 301 | 0.080 |
Why?
| | Convection | 1 | 2005 | 1 | 0.080 |
Why?
| | Osmosis | 1 | 2005 | 9 | 0.080 |
Why?
| | Structure-Activity Relationship | 1 | 2005 | 55 | 0.080 |
Why?
| | Aortography | 1 | 2004 | 14 | 0.070 |
Why?
| | Trauma Centers | 1 | 2004 | 13 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 481 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2013 | 29 | 0.070 |
Why?
| | Lactic Acid | 1 | 2002 | 18 | 0.070 |
Why?
| | Publication Bias | 1 | 2002 | 8 | 0.070 |
Why?
| | Rats | 1 | 2005 | 941 | 0.070 |
Why?
| | Glomerular Filtration Rate | 2 | 2013 | 75 | 0.070 |
Why?
| | Oxygen Consumption | 1 | 2002 | 59 | 0.070 |
Why?
| | Physical Fitness | 1 | 2002 | 54 | 0.060 |
Why?
| | Angiography | 1 | 2002 | 54 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2002 | 369 | 0.060 |
Why?
| | Heart Rate | 1 | 2002 | 165 | 0.060 |
Why?
| | Spinal Cord Diseases | 1 | 2002 | 50 | 0.060 |
Why?
| | Lung | 1 | 2021 | 164 | 0.050 |
Why?
| | Pregnancy | 1 | 2021 | 443 | 0.050 |
Why?
| | Malocclusion, Angle Class III | 1 | 2018 | 1 | 0.050 |
Why?
| | Osteotomy, Sagittal Split Ramus | 1 | 2018 | 1 | 0.050 |
Why?
| | Cephalometry | 1 | 2018 | 5 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2017 | 34 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2018 | 132 | 0.050 |
Why?
| | Time-to-Treatment | 1 | 2017 | 31 | 0.050 |
Why?
| | Survival Rate | 1 | 2018 | 464 | 0.040 |
Why?
| | Kidney Failure, Chronic | 1 | 2019 | 168 | 0.040 |
Why?
| | Osteotomy | 1 | 2018 | 153 | 0.040 |
Why?
| | Cerebral Infarction | 1 | 2017 | 158 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 467 | 0.040 |
Why?
| | Reperfusion | 1 | 2015 | 12 | 0.040 |
Why?
| | Brain | 1 | 2005 | 1474 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2017 | 327 | 0.040 |
Why?
| | Aquaporin 4 | 1 | 2014 | 11 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2014 | 68 | 0.040 |
Why?
| | Speech Disorders | 1 | 2014 | 14 | 0.040 |
Why?
| | Nerve Degeneration | 1 | 2014 | 56 | 0.040 |
Why?
| | Forecasting | 1 | 2014 | 129 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2014 | 64 | 0.040 |
Why?
| | Time Factors | 2 | 2011 | 1894 | 0.040 |
Why?
| | Disease Management | 1 | 2015 | 149 | 0.040 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 74 | 0.040 |
Why?
| | Iohexol | 1 | 2013 | 5 | 0.030 |
Why?
| | Radiography, Interventional | 1 | 2013 | 30 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 529 | 0.030 |
Why?
| | Biopsy | 1 | 2013 | 278 | 0.030 |
Why?
| | Contrast Media | 1 | 2013 | 146 | 0.030 |
Why?
| | Comorbidity | 1 | 2013 | 555 | 0.030 |
Why?
| | Coronary Angiography | 1 | 2011 | 105 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 119 | 0.030 |
Why?
| | Ultrasonography | 1 | 2011 | 198 | 0.030 |
Why?
| | Middle Cerebral Artery | 1 | 2009 | 22 | 0.030 |
Why?
| | Registries | 1 | 2011 | 195 | 0.030 |
Why?
| | Carotid Arteries | 1 | 2009 | 55 | 0.030 |
Why?
| | Acute Disease | 1 | 2009 | 272 | 0.020 |
Why?
| | Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 1 | 0.020 |
Why?
| | Cyclin D | 1 | 2008 | 1 | 0.020 |
Why?
| | Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 3 | 0.020 |
Why?
| | Cyclins | 1 | 2008 | 6 | 0.020 |
Why?
| | Symporters | 1 | 2008 | 6 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 17 | 0.020 |
Why?
| | Hepatocytes | 1 | 2008 | 12 | 0.020 |
Why?
| | Ligation | 1 | 2008 | 37 | 0.020 |
Why?
| | Liver Regeneration | 1 | 2008 | 27 | 0.020 |
Why?
| | United States | 1 | 2015 | 2402 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2008 | 122 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2008 | 306 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2008 | 232 | 0.020 |
Why?
| | Up-Regulation | 1 | 2008 | 214 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2013 | 1059 | 0.020 |
Why?
| | Myelography | 1 | 2002 | 10 | 0.020 |
Why?
| | Arteriosclerosis | 1 | 2002 | 18 | 0.020 |
Why?
| | Aortic Aneurysm | 1 | 2002 | 17 | 0.020 |
Why?
| | Cohort Studies | 1 | 2008 | 1911 | 0.020 |
Why?
| | Obesity, Morbid | 1 | 2002 | 78 | 0.010 |
Why?
|
|
Chen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|